Dialysate and plasma meropenem concentrations in continuous intraperitoneal regimen during peritoneal-dialysis-related peritonitis

A single dose of intraperitoneal (IP) meropenem is recommended for peritoneal-dialysis (PD)-related peritonitis stemming from extended-spectrum [beta]-lactamase-producing organisms. However, data on IP meropenem is limited. This prospective, descriptive study was conducted to examine plasma and dial...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2025-01, Vol.20 (1), p.e0312160
Hauptverfasser:	Srithongkul, Thatsaphan, Raksasuk, Sukit, Techajongnumchai, Bulaporn, Sritippayawan, Suchai, Koomanachai, Pornpan
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics Automation Biology and Life Sciences Blood Causes of Chromatography Clinical trials Complications and side effects Continuous ambulatory peritoneal dialysis Dialysate Dialysis Drug dosages Drug therapy Effluents Hemodialysis Infections Leukocytes Liquid chromatography Medicine and Health Sciences Meropenem Patient outcomes Patients Peritoneal dialysis Peritoneum Peritonitis Pharmacokinetics Plasma Research and Analysis Methods Urine β Lactamase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!